MTOR and obesity disorder: In addition, pharmacological inhibition of the mechanistic target of rapamycin (mTOR) by rapamycin ameliorates age-dependent obesity phenotypes associated with dysregulated mTOR complex 1 (mTORC1) signaling in POMC neurons [13, 14].